PT-141

Research Overview

PT-141 (Bremelanotide) is an investigational synthetic peptide compound that has generated scientific interest due to its relationship with melanocortin receptor signaling and peptide-based molecular research. Studies involving PT-141 have focused on understanding its peptide structure, receptor interactions, and activity within controlled laboratory research environments.

As a synthetic analog derived from melanocortin peptide research, PT-141 represents an area of investigation involving receptor biology, cellular signaling mechanisms, and the relationship between peptide structures and molecular communication pathways.

Areas of Research Interest Include:

• Melanocortin receptor signaling
• Peptide-receptor interaction studies
• Neuropeptide research pathways
• Molecular signaling mechanisms
• Synthetic peptide analog analysis

Scientific Background

PT-141 is a synthetic cyclic heptapeptide analog derived from research involving melanocortin pathways. Its molecular structure has been investigated within peptide research models focused on receptor interactions, signaling activity, and the relationship between synthetic peptides and biological communication systems.

Laboratory investigations continue to evaluate PT-141’s molecular characteristics, peptide stability, and interactions with melanocortin receptor systems. Research involving melanocortin analogs contributes to a broader understanding of peptide structure, receptor biology, and cellular signaling mechanisms.

Molecular Information

Molecular Formula: C50H68N14O10

Molecular Weight: 1025.2 g/mol

Research Use Only

Products offered by Obsidian Research are intended solely for laboratory research purposes. These products are not intended for human or veterinary consumption and are not approved for clinical use.